Synergistic anti-tumor efficacy of combined TLR3 and CD40 neoantigen vaccine requires Batf3-dependent dendritic cells
Year: 2018
Type: conference-abstract
Source: The Journal of Immunology
Institution: Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4313359565
